FundedIQ
Biotechnology

LambdaVision: Funding, Investors & Team (Sep 2026)

LambdaVision, Inc. is working to bring to market a retinal implant that can help restore vision for individuals with retinitis pigmentosa (RP) and age-related macular degeneration (AMD).

www.lambdavision.com/home.html LinkedIn Farmington, United States 1-10 employees
Total raised
$7.0M
Rounds
3
Latest
Seed
Nov 2025

LambdaVision has raised $7.0M across 3 funding rounds on record, the most recent a Seed of $7.0M announced in Nov 2025.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

LambdaVision Company Profile and Key Stats

Total funding raised
$7.0M
across 3 rounds on record
Funding rounds on record
3
2 with no disclosed amount
Latest funding round
Seed
$7.0M in Nov 2025
Employees
1-10
reported band
Headquarters
Farmington, United States

Latest funding round on record: Nov 2025.

LambdaVision Funding Rounds

Date
Round
Amount
Seed
$7.0M
Seed
Undisclosed
Undisclosed round
Undisclosed

2 of 3 rounds were announced without a disclosed amount and are excluded from the total.

LambdaVision announced an undisclosed round in May 2024; the amount was not disclosed.

1 years later, a Seed was announced in May 2025 with no disclosed amount.

6 months later, a Seed of $7.0M was announced in Nov 2025.

LambdaVision Founders and Leadership Team

Name
Role
Contact
Robert Birge
Founder
Nicole L. Wagner
Locked

Contact details for the LambdaVision team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

LambdaVision Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
16,575
$3.1M

LambdaVision's latest round of $7.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like LambdaVision in Biotechnology and Farmington

Companies Similar to LambdaVision

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

LambdaVision Funding FAQs

What does LambdaVision do?

LambdaVision, Inc. is working to bring to market a retinal implant that can help restore vision for individuals with retinitis pigmentosa (RP) and age-related macular degeneration (AMD).

How much funding has LambdaVision raised?

LambdaVision has raised $7.0M across 3 rounds on record. The most recent is a Seed of $7.0M announced in Nov 2025.

When did LambdaVision last raise funding?

LambdaVision's most recent funding round on record is a Seed of $7.0M, announced in Nov 2025.

Who founded LambdaVision?

FundedIQ lists Robert Birge (Founder) at LambdaVision.

Where is LambdaVision headquartered?

LambdaVision is based in Farmington, Connecticut, United States.

How many employees does LambdaVision have?

LambdaVision is in the 1-10 employee band.

How does LambdaVision's funding compare to other Biotechnology startups?

LambdaVision's latest round of $7.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's LambdaVision Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for LambdaVision is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.